National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Cancer
< Back to Main
In English     En español
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 37  :  Genetic Testing <  >  

Laboratory tests can determine whether a person carries some of the genetic alterations that can increase the risk of developing certain cancers. For example, women who inherit certain forms of a gene called BRCA1 or BRCA2 have an elevated risk of developing breast cancer. For women with a family history of breast cancer, taking such a test may relieve uncertainty about their future risk. However, the information obtained from genetic tests is often complex and difficult to interpret. The decision to undergo genetic testing should therefore be a personal, voluntary one and should only be made in conjunction with appropriate genetic counseling.

Genetic Testing

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov